Follow
Sean J. Mulvihill
Sean J. Mulvihill
University of Utah SOM
Verified email at hsc.utah.edu - Homepage
Title
Cited by
Cited by
Year
Phenotype and genotype of pancreatic cancer cell lines
EL Deer, J González-Hernández, JD Coursen, JE Shea, J Ngatia, ...
Pancreas 39 (4), 425-435, 2010
11142010
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
CR Pullinger, C Eng, G Salen, S Shefer, AK Batta, SK Erickson, ...
The Journal of clinical investigation 110 (1), 109-117, 2002
6852002
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
AB Benson 3rd, TA Abrams, E Ben-Josef, PM Bloomston, JF Botha, ...
Journal of the National Comprehensive Cancer Network: JNCCN 7 (4), 350-391, 2009
5902009
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression
A Fukuda, SC Wang, JP Morris, AE Folias, A Liou, GE Kim, S Akira, ...
Cancer cell 19 (4), 441-455, 2011
5792011
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates
K E Poruk, D Z Gay, K Brown, J D Mulvihill, K M Boucher, C L Scaife, ...
Current molecular medicine 13 (3), 340-351, 2013
4662013
Pancreatic adenocarcinoma, version 2.2014
MA Tempero, MP Malafa, SW Behrman, AB Benson, ES Casper, ...
Journal of the National Comprehensive Cancer Network 12 (8), 1083-1093, 2014
4142014
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial
S Mulvihill, R Warren, A Venook, A Adler, B Randlev, C Heise, D Kirn
Gene therapy 8 (4), 308-315, 2001
3752001
Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines
MA Tempero, JP Arnoletti, SW Behrman, E Ben-Josef, AB Benson, ...
Journal of the National Comprehensive Cancer Network 10 (6), 703-713, 2012
3442012
Early detection of sporadic pancreatic cancer: summative review
ST Chari, K Kelly, MA Hollingsworth, SP Thayer, DA Ahlquist, ...
Pancreas 44 (5), 693-712, 2015
3282015
Screening for pancreatic cancer: why, how, and who?
KE Poruk, MA Firpo, DG Adler, SJ Mulvihill
Annals of surgery 257 (1), 17-26, 2013
3272013
Synthesis of phospholipids and membranes in prebiotic conditions
WR Hargreaves, SJ Mulvihill, DW Deamer
Nature 266 (5597), 78-80, 1977
2801977
Surgery: basic science and clinical evidence
J Norton, RR Bollinger, AE Chang, SF Lowry
Springer, 2012
2592012
Hospital volume influences outcome in patients undergoing pancreatic resection for cancer.
RE Glasgow, SJ Mulvihill
Western journal of medicine 165 (5), 294, 1996
2371996
Laparoscopic splenectomy: the emerging standard
RE Glasgow, LF Yee, SJ Mulvihill
Surgical endoscopy 11, 108-112, 1997
220*1997
Safety and timing of nonobstetric abdominal surgery in pregnancy
BC Visser, RE Glasgow, KK Mulvihill, SJ Mulvihill
Digestive surgery 18 (5), 409-417, 2001
2112001
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma
G Von Figura, A Fukuda, N Roy, ME Liku, JP Morris Iv, GE Kim, HA Russ, ...
Nature cell biology 16 (3), 255-267, 2014
2032014
The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma
RE Glasgow, JA Showstack, PP Katz, CU Corvera, RS Warren, ...
Archives of surgery 134 (1), 30-35, 1999
2031999
Wounds: biology, pathology, and management
M Li, JA Norton, RR Bollinger, AE Chang, SF Lowry, SJ Mulvihill, HI Pass, ...
Essential practice of surgery: basic science and clinical evidence, 77-88, 2003
1882003
Changing management of gallstone disease during pregnancy
RE Glasgow, BC Visser, HW Harris, MG Patti, SJ Kilpatrick, SJ Mulvihill
Surgical endoscopy 12, 241-246, 1998
1871998
Gastrointestinal perforation and the acute abdomen
JT Langell, SJ Mulvihill
Medical Clinics of North America 92 (3), 599-625, 2008
1642008
The system can't perform the operation now. Try again later.
Articles 1–20